MiR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway

Experimental Lung Research

Volumn 41, Issue 5, 2015, Pages 261-269

  Liu, Fen ^a   Li, Yong ^a   Jiang, Rong ^a   Nie, Cheng ^a   Zeng, Zhenguo ^a   Zhao, Ning ^a   Huang, Caixue ^a   Shao, Qiang ^a   Ding, Chengzhi ^a   Qing, Cheng ^a   Xia, Liang ^a   Zeng, Erming ^a   Qian, Kejian ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Alveolar macrophage; Cholinergic anti inflammatory pathway; MicroRNA 132; NF B; STAT3

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MICRORNA 132; STAT3 PROTEIN; ACETYLCHOLINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; MESSENGER RNA; MICRORNA; MIRN132 MICRORNA, RAT;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RESPIRATORY TRACT INFLAMMATION; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; CHEMICALLY INDUCED; DOWN REGULATION; DRUG EFFECTS; INFLAMMATION; LUNG ALVEOLUS; METABOLISM; RNA PROCESSING; UPREGULATION;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; CELL LINE; CHOLINERGIC AGENTS; DOWN-REGULATION; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MICRORNAS; NF-KAPPA B; PULMONARY ALVEOLI; RATS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; UP-REGULATION;

EID: 84930846551     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2015.1004206     Document Type: Article

References (23)

1. Guirgis FW, Khadpe JD, Kuntz GM, Wears RL, Kalynych CJ, Jones AE: Persistent organ dysfunction after severe sepsis: A systematic review. J Crit Care. 2014;29:320-326.
2. Matthay MA,Ware LB, Zimmerman GA: The acute respiratory distress syndrome. J Clin Invest. 2012;122:2731-2740.
3. Crimi E, Slutsky AS: Inflammation and the acute respiratory distress syndrome. Best Pract Res Clin Anaesthesiol. 2004;18:477-492.
4. Maus UA, Koay MA, Delbeck T, Mack M, Ermert M, Ermert L, Blackwell TS, Christman JW, Schlöndorff D, Seeger W, Lohmeyer J: Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice. Am J Physiol Lung Cell Mol Physiol. 2002;282:L1245-L1252.
5. Morris PE, Zeno B, Bernard AC, Huang X, Das S, Edeki T, Simonson SG, Bernard GR: A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/ pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock. Crit Care. 2012;16:R31.
6. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996;334:1697-1702.
7. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384-388.
8. Tracey KJ: Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289-296.
9. Yoshikawa H, Kurokawa M, Ozaki N, Nara K, Atou K, Takada E, Kamochi H, Suzuki N: Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol. 2006;146:116-123.
10. Metz CN, Tracey KJ: It takes nerve to dampen inflammation. Nat Immunol. 2005;6:756-757.
11. Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, Soreq H: MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity. 2009;31:965-973.
12. Maharshak N, Shenhar-Tsarfaty S, Aroyo N, Orpaz N, Guberman I, Canaani J, Halpern Z, Dotan I, Berliner S, Soreq H: MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1346-1353.
13. Taganov KD, Boldin MP, Chang KJ, Baltimore D: NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103:12481-12486.
14. Nahid MA, Yao B, Dominguez-Gutierrez PR, Kesavalu L, Satoh M, Chan EK: Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212. J Immunol. 2013;190:1250-1263.
15. Meshorer E, Soreq H: Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci. 2006;29:216-224.
16. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458-462.
17. Su X, Matthay MA,Malik AB: Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol. 2010;184:401-410.
18. Lv Y, Hu S, Lu J, Dong N, Liu Q, Du M, Zhang H: Upregulating nonneuronal cholinergic activity decreases TNF release from lipopolysaccharide-stimulated RAW264.7 cells.Mediators Inflamm. 2014;2014:Article ID 873728, 10 pages.
19. Zingarelli B: Nuclear factor-kappaB. Crit Care Med. 2005;33:S414-S416.
20. Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J, Tracey KJ, Al-Abed Y, Metz CN: Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med. 2005;201:1113-1123.
21. Sun Y, Li Q, Gui H, Xu DP, Yang YL, Su DF, Liu X: MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Res. 2013;23:1270-1283.
22. Samavati L, Rastogi R,DuW,Huttemann M, Fite A, Franchi L: STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol. 2009;46:1867-1877.
23. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Eumatsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE: Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6:844-851.